232 related articles for article (PubMed ID: 31023275)
21. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial.
Manlhiot C; Newburger JW; Low T; Dahdah N; Mackie AS; Raghuveer G; Giglia TM; Dallaire F; Mathew M; Runeckles K; Pahl E; Harahsheh AS; Norozi K; de Ferranti SD; Friedman K; Yetman AT; Kutty S; Mondal T; McCrindle BW;
Can J Cardiol; 2020 Oct; 36(10):1598-1607. PubMed ID: 32621885
[TBL] [Abstract][Full Text] [Related]
22. Perioperative complications in patients on low-molecular-weight heparin bridging therapy.
Breen DT; Chavalertsakul N; Paul E; Gruen RL; Serpell J
ANZ J Surg; 2016 Mar; 86(3):167-72. PubMed ID: 23336820
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism in lymphoma: how effectively are we treating patients?
Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Daw HA
Am J Clin Oncol; 2009 Oct; 32(5):521-3. PubMed ID: 19546801
[TBL] [Abstract][Full Text] [Related]
24. Management patterns and outcomes in symptomatic venous thromboembolism following allogeneic hematopoietic stem cell transplantation. A 15-years experience at a single center.
Labrador J; González-Rivero J; Monroy R; Lozano FS; López-Corral L; Caballero MD; Bastida JM; González-Porras JR
Thromb Res; 2016 Jun; 142():52-6. PubMed ID: 26922092
[TBL] [Abstract][Full Text] [Related]
25. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.
Douketis JD; Spyropoulos AC; Kaatz S; Becker RC; Caprini JA; Dunn AS; Garcia DA; Jacobson A; Jaffer AK; Kong DF; Schulman S; Turpie AG; Hasselblad V; Ortel TL;
N Engl J Med; 2015 Aug; 373(9):823-33. PubMed ID: 26095867
[TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness of low-molecular-weight heparins versus other anticoagulants in major orthopedic surgery: a systematic review and meta-analysis.
Sobieraj DM; Coleman CI; Tongbram V; Chen W; Colby J; Lee S; Kluger J; Makanji S; Ashaye A; White CM
Pharmacotherapy; 2012 Sep; 32(9):799-808. PubMed ID: 22744711
[TBL] [Abstract][Full Text] [Related]
27. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
[TBL] [Abstract][Full Text] [Related]
28. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
[TBL] [Abstract][Full Text] [Related]
29. Cancer patients requiring interruption of long-term warfarin because of surgery or chemotherapy induced thrombocytopenia: the use of fixed sub-therapeutic doses of low-molecular weight heparin.
Saccullo G; Malato A; Raso S; Santoro M; Zammit V; Casuccio A; Siragusa S
Am J Hematol; 2012 Apr; 87(4):388-91. PubMed ID: 22374861
[TBL] [Abstract][Full Text] [Related]
30. Association of Adding Aspirin to Warfarin Therapy Without an Apparent Indication With Bleeding and Other Adverse Events.
Schaefer JK; Li Y; Gu X; Souphis NM; Haymart B; Kline-Rogers E; Almany SL; Kaatz S; Kozlowski JH; Krol GD; Sood SL; Froehlich JB; Barnes GD
JAMA Intern Med; 2019 Apr; 179(4):533-541. PubMed ID: 30830172
[TBL] [Abstract][Full Text] [Related]
31. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
32. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
33. Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.
Hylek EM; Held C; Alexander JH; Lopes RD; De Caterina R; Wojdyla DM; Huber K; Jansky P; Steg PG; Hanna M; Thomas L; Wallentin L; Granger CB
J Am Coll Cardiol; 2014 May; 63(20):2141-2147. PubMed ID: 24657685
[TBL] [Abstract][Full Text] [Related]
34. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
Wells PS; Kovacs MJ; Bormanis J; Forgie MA; Goudie D; Morrow B; Kovacs J
Arch Intern Med; 1998 Sep; 158(16):1809-12. PubMed ID: 9738611
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
Le Maître A; Ding K; Shepherd FA; Leighl N; Arnold A; Seymour L;
J Thorac Oncol; 2009 May; 4(5):586-94. PubMed ID: 19357539
[TBL] [Abstract][Full Text] [Related]
36. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
Bahit MC; Lopes RD; Wojdyla DM; Held C; Hanna M; Vinereanu D; Hylek EM; Verheugt F; Goto S; Alexander JH; Wallentin L; Granger CB
Heart; 2017 Apr; 103(8):623-628. PubMed ID: 27798052
[TBL] [Abstract][Full Text] [Related]
37. Safety of ablation for atrial fibrillation with therapeutic INR: comparison with transition to low-molecular-weight heparin.
Saad EB; Costa IP; Costa RE; Inácio LA; Slater C; Camiletti A; Moura Neto DG; Maldonado P; Camanho LE; Polanczky CA
Arq Bras Cardiol; 2011 Oct; 97(4):289-96. PubMed ID: 21861038
[TBL] [Abstract][Full Text] [Related]
38. Postoperative Deep Vein Thrombosis, Pulmonary Embolism, and Myocardial Infarction: Complications After Therapeutic Anticoagulation in the Patient With Spine Trauma.
Shiu B; Le E; Jazini E; Weir TB; Costales T; Caffes N; Paryavi E; O'Hara N; Gelb DE; Koh EY; Ludwig SC
Spine (Phila Pa 1976); 2018 Jul; 43(13):E766-E772. PubMed ID: 29215498
[TBL] [Abstract][Full Text] [Related]
39. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of thromboembolic prophylaxis after total knee arthroplasty.
Westrich GH; Haas SB; Mosca P; Peterson M
J Bone Joint Surg Br; 2000 Aug; 82(6):795-800. PubMed ID: 10990299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
